BERGEM·HEALTH
Home Doctors Prof. Dr. Hakan Harputluoğlu, MD
MEDICAL ONCOLOGY · MEMORIAL BAHÇELIEVLER

Prof. Dr. Hakan Harputluoğlu, MD

Professor of Medical Oncology · Memorial Bahçelievler Hospital
Prof. Dr. Hakan Harputluoğlu is a medical oncologist at Memorial Bahçelievler Hospital. He completed his medical oncology sub-specialty at the Hacettepe University Cancer Institute and held a long professorship at İnönü University Turgut Özal Medical Center in Malatya before joining Memorial. His clinical research focuses on solid tumours including gastric, lung and skin cancers.
Specialties: Oncology
19+
years in oncology
90+
publications (ResearchGate)
1,300+
citations
Medical OncologyGastric CancerLung CancerMelanomaHacettepe Cancer Institute
A BergemHealth coordinator arranges contact with the professor within 24–48 hours on business days.
Direct contract with BergemHealth
CONSULTATION LANGUAGES
TR Turkish · native
EN English · professional
RU Russian · via BergemHealth coordinator
UK Ukrainian · via BergemHealth coordinator
ISTANBUL · 06/2026
EDUCATION & CAREER

Timeline

Career milestones.

2007-2009
Medical Oncology Specialist
İnönü University Turgut Özal Medical Center, Malatya
2009-2010
Specialist
İstanbul Şişli Hamidiye Etfal Training and Research Hospital
2010
Specialist
Malatya Training and Research Hospital
2010-2024 (approx)
Professor of Medical Oncology
İnönü University Turgut Özal Medical Center, Malatya
current
Medical Oncology Specialist
Memorial Bahçelievler Hospital
PUBLICATIONS

Scientific work

Selected peer-reviewed publications.

  • 2013
    J BUON
    «Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)»
    · co-author
  • 2012
    Oncol Res Treat (Onkologie)
    «Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience»
    · co-author
  • 2014
    J BUON
    «Outcome of 561 non-metastatic triple negative breast cancer patients: Multi-center experience from Turkey»
    · co-author
  • 2008
    J Neurooncol
    «Prognostic factors in breast cancer patients with brain metastases»
    · first author
  • 2007
    Hum Pathol
    «Potential targeted therapy options in the management of basal cell subtype of breast carcinoma»
    · first author
  • 2022
    J Clin Oncol
    «Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study)»
    · co-author
REQUEST

Tell me about your case — I’ll read it personally.

Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.

Open the consultation form
  • Reply within 4 hours during business hours
  • Confidentiality guaranteed
  • Coordinator-translator inside the doctor’s office
  • Tumour board of 2–3 professors within 72 hours